You are here: All Products  > Tarrex Biopharma, a US-China Startup, Approved to Start US Cancer Drug Trial

Tarrex Biopharma, a US-China Startup, Approved to Start US Cancer Drug Trial

Price: $5.00
Available
Get instant access to this article for unlimited viewing and/or downloading for seven days.

Back to products